Given the importance of canonical ceramides and 1-deoxy(dihydro)ceramides in obesity and neuropathy, respectively15,32, we hypothesized that SPT inhibition could influence the observed obesity and neuropathy phenotypes. Here, AGXT is linked to obesity due to melanocortin 4 receptor deficiency.